INFASURF (Ony, Inc.)
Welcome to the PulseAid listing for the INFASURF drug offered from Ony, Inc.. This Alveolar Surface Tension Reduction [PE],Surfactant [EPC],Surfactant Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Ony, Inc. |
NON-PROPRIETARY NAME: | CALFACTANT |
SUBSTANCE NAME: | CALFACTANT |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Alveolar Surface Tension Reduction [PE],Surfactant [EPC],Surfactant Activity [MoA] |
ROUTE: | ENDOTRACHEAL |
DOSAGE FORM: | SUSPENSION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2011-07-21 |
END MARKETING DATE: | 0000-00-00 |
INFASURF HUMAN PRESCRIPTION DRUG Details:
Item Description | INFASURF from Ony, Inc. |
LABELER NAME: | Ony, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 35.7(mg/mL) |
START MARKETING DATE: | 2011-07-21 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 61938-456_d37c02fb-1bed-4400-92d2-50a67e539beb |
PRODUCT NDC: | 61938-456 |
APPLICATION NUMBER: | NDA020521 |
Other CALFACTANT Pharmaceutical Manufacturers / Labelers: